Clinical Cancer Advances 2008: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology

Objective responses in a phase I dose-escalation study of SGN-35, a novel antibody-drug conjugate (ADC) targeting CD30, in patients with relapsed or refractory Hodgkin lymphoma

(2017) A. Younes et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant ovarian suppression combined with tamoxifen or anastrozole, alone or in combination with zoledronic acid, in premenopausal women with hormone-responsive, stage I and II breast cancer: First efficacy results from ABCSG-12.

(2017) M. Gnant et al.   JOURNAL OF CLINICAL ONCOLOGY

Locoregional control in locally advanced breast cancer using neoadjuvant chemotherapy followed by breast conservation

(2017) M. O. Meyers et al.   JOURNAL OF CLINICAL ONCOLOGY

Do clinical practice guidelines (CPGs) change clinical practice? An analysis of CPG impact on referral and treatment patterns for neoadjuvant chemotherapy in bladder cancer

(2017) B. J. Miles et al.   JOURNAL OF CLINICAL ONCOLOGY

Cardiovascular disease in adult survivors of childhood and adolescent cancer: A report from the Childhood Cancer Survivor Study (CCSS)

(2017) D. A. Mulrooney et al.   JOURNAL OF CLINICAL ONCOLOGY

Risk of therapy related myelodysplasia and acute myeloid leukemia (t-MDS/AML) in children exposed to alkylating agents, anthracyclines, platinum compounds and epipodophyllotoxins: a report from Children’s Oncology Group (COG)

(2017) S. M. Shankar et al.   JOURNAL OF CLINICAL ONCOLOGY

Use of a genome-wide linkage screen to identify a hereditary neuroblastoma predisposition locus at chromosome 2p24–23

(2017) Y. P. Mosse et al.   JOURNAL OF CLINICAL ONCOLOGY

A randomized phase III study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with localized, unresectable pancreatic cancer: E4201

(2017) P. J. Loehrer et al.   JOURNAL OF CLINICAL ONCOLOGY

CONKO-001: Final results of the randomized, prospective, multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer (PC)

(2017) P. Neuhaus et al.   JOURNAL OF CLINICAL ONCOLOGY

A phase II, randomized, non-comparative clinical trial of the effect of bevacizumab (BV) alone or in combination with irinotecan (CPT) on 6-month progression free survival (PFS6) in recurrent, treatment-refractory glioblastoma (GBM)

(2017) T. F. Cloughesy et al.   JOURNAL OF CLINICAL ONCOLOGY

KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: The CRYSTAL experience

(2017) E. Van Cutsem et al.   JOURNAL OF CLINICAL ONCOLOGY

Activity of sorafenib (SOR) in patients (pts) with imatinib (IM) and sunitinib (SU)-resistant (RES) gastrointestinal stromal tumors (GIST): A phase II trial of the University of Chicago Phase II Consortium

(2017) L. Wiebe et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer Screening before and after Switching to a High-Deductible Health Plan

(2013) J. Frank Wharam et al.   ANNALS OF INTERNAL MEDICINE

Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study

(2008) Ezra E.W. Cohen et al.   JOURNAL OF CLINICAL ONCOLOGY

Refractory Thyroid Cancer: A Paradigm Shift in Treatment Is Not Far Off

(2008) David G. Pfister et al.   JOURNAL OF CLINICAL ONCOLOGY

Current and Future Utilization of Services From Medical Oncologists

(2008) Joan L. Warren et al.   JOURNAL OF CLINICAL ONCOLOGY

Efficacy, Toxicity, and Quality of Life in Older Women With Early-Stage Breast Cancer Treated With Letrozole or Placebo After 5 Years of Tamoxifen: NCIC CTG Intergroup Trial MA.17

(2008) Hyman B. Muss et al.   JOURNAL OF CLINICAL ONCOLOGY

Late Extended Adjuvant Treatment With Letrozole Improves Outcome in Women With Early-Stage Breast Cancer Who Complete 5 Years of Tamoxifen

(2008) Paul E. Goss et al.   JOURNAL OF CLINICAL ONCOLOGY

Double-Blind Randomized Phase II Study of the Combination of Sorafenib and Dacarbazine in Patients With Advanced Melanoma: A Report From the 11715 Study Group

(2008) David F. McDermott et al.   JOURNAL OF CLINICAL ONCOLOGY

Targeting Polo-Like Kinase: Learning Too Little Too Late?

(2008) David Olmos et al.   JOURNAL OF CLINICAL ONCOLOGY

Assessing the Measure of a New Drug: Is Survival the Only Thing That Matters?

(2008) Daniel J. Sargent et al.   JOURNAL OF CLINICAL ONCOLOGY

Safety and Efficacy of Darbepoetin Alfa in Previously Untreated Extensive-Stage Small-Cell Lung Cancer Treated With Platinum Plus Etoposide

(2008) Robert Pirker et al.   JOURNAL OF CLINICAL ONCOLOGY

Incidence Trends for Human Papillomavirus–Related and –Unrelated Oral Squamous Cell Carcinomas in the United States

(2008) Anil K. Chaturvedi et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Trial of Sorafenib in Advanced Thyroid Cancer

(2008) Vandana Gupta-Abramson et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven

(2008) Gerhardt Attard et al.   JOURNAL OF CLINICAL ONCOLOGY

Evaluation of Trends in the Cost of Initial Cancer Treatment

(2008) J. L. Warren et al.   JNCI-Journal of the National Cancer Institute

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

(2008) Alexander MM Eggermont et al.   LANCET

Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls

(2008)   LANCET

Motesanib Diphosphate in Progressive Differentiated Thyroid Cancer

(2008) Steven I. Sherman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Detection of Mutations inEGFRin Circulating Lung-Cancer Cells

(2008) Shyamala Maheswaran et al.   NEW ENGLAND JOURNAL OF MEDICINE

Is It Time to Stratify for BRCA Mutation Status in Therapeutic Trials in Ovarian Cancer?

(2007) Noah D. Kauff   JOURNAL OF CLINICAL ONCOLOGY